Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares Issued
Ratios

Madrigal Pharmaceuticals (MDGL) Long-Term Debt Issuances (2022 - 2023)

Historic Long-Term Debt Issuances for Madrigal Pharmaceuticals (MDGL) over the last 4 years, with Q3 2023 value amounting to $15.0 million.

  • Madrigal Pharmaceuticals' Long-Term Debt Issuances changed N/A to $15.0 million in Q3 2023 from the same period last year, while for Jun 2024 it was $15.0 million, marking a year-over-year decrease of 7000.0%. This contributed to the annual value of $65.0 million for FY2023, which is 3000.0% up from last year.
  • According to the latest figures from Q3 2023, Madrigal Pharmaceuticals' Long-Term Debt Issuances is $15.0 million.
  • In the past 5 years, Madrigal Pharmaceuticals' Long-Term Debt Issuances ranged from a high of $50.0 million in Q2 2022 and a low of $15.0 million during Q2 2023